Fig. 5: p38α inhibition downregulates CRC-SC markers in an in vivo model. | Cell Death & Disease

Fig. 5: p38α inhibition downregulates CRC-SC markers in an in vivo model.

From: Pharmacological targeting of the novel β-catenin chromatin-associated kinase p38α in colorectal cancer stem cell tumorspheres and organoids

Fig. 5

A Mice treatment scheme. B Hematoxylin and eosin staining of AOM-treated APCMin/+ mice injected with the p38α inhibitor SB202190 or DMSO. Original magnification: 200x. C Immunohistochemistry analysis of colon tissue sections from C57BL/6 and AOM-treated APCMin/+ mice injected with the p38α inhibitor SB202190 or DMSO. Original magnification: 100x.

Back to article page